STERIS plc (STE)
NYSE · Healthcare · Medical Devices
STERIS plc is a Healthcare company with a market capitalization of $22.86B, a trailing P/E ratio of 28.7, and a dividend yield of 1.07%.
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q4 2026 | May 11, 2026 | $2.83 | $2.85 | -0.7% |
| Q3 2026 | February 4, 2026 | $2.53 | $2.53 | +0.0% |
| Q2 2026 | November 5, 2025 | $2.47 | $2.38 | +3.8% |
| Q1 2026 | August 6, 2025 | $2.34 | $2.26 | +3.5% |
| Q4 2025 | May 14, 2025 | $2.74 | $2.60 | +5.4% |
| Q3 2025 | February 5, 2025 | $2.32 | $2.32 | +0.0% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,439,561 | 2.48% | 3.3 | +4.2% |
| June 30, 2026 | 2,340,486 | 2.38% | 2.3 | +16.2% |
| June 15, 2026 | 2,013,638 | 2.05% | 2.6 | +11.5% |
| May 29, 2026 | 1,805,984 | 1.84% | 2.3 | -16.9% |
| May 15, 2026 | 2,173,072 | 2.21% | 2.4 | +16.4% |
| April 30, 2026 | 1,866,049 | 1.89% | 2.7 | +15.3% |
| April 15, 2026 | 1,617,823 | 1.64% | 2.8 | -11.3% |
| March 31, 2026 | 1,823,241 | 1.85% | 2.3 | +3.7% |
Other Medical Devices Stocks
Frequently Asked Questions
What is STERIS plc's market cap?
As of August 13, 2026, STERIS plc (STE) has a market capitalization of $22.86B.
What is STERIS plc's P/E ratio?
STERIS plc trades at a trailing price-to-earnings (P/E) ratio of 28.7. Its forward P/E is 21.1.
Does STERIS plc pay a dividend?
Yes — STERIS plc pays a dividend yielding 1.07%, an annual payout of $2.52 per share.
What sector is STE in?
STERIS plc is in the Healthcare sector, specifically the Medical Devices industry.
What is STERIS plc's short interest?
As of the July 15, 2026 FINRA settlement, 2,439,561 STE shares were sold short, or 2.48% of shares outstanding. Days to cover: 3.3. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was STERIS plc's revenue?
In its latest reported fiscal year (ending March 31, 2026), STERIS plc reported revenue of $5.94B and net income of $785.10M.
Ask your own questions about STE
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.